Cargando…
Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells
Loss of DNA mismatch repair has been observed in a variety of human cancers. Recent studies have shown that loss of DNA mismatch repair results in resistance to cisplatin but not oxaliplatin, suggesting that the mismatch repair proteins serve as a detector for cisplatin but not oxaliplatin adducts....
Autores principales: | Nehmé, A, Baskaran, R, Nebel, S, Fink, D, Howell, S B, Wang, J Y J, Christen, R D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362240/ https://www.ncbi.nlm.nih.gov/pubmed/10098743 http://dx.doi.org/10.1038/sj.bjc.6690176 |
Ejemplares similares
-
Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin
por: Cenni, B, et al.
Publicado: (1999) -
Effect of c-Abl tyrosine kinase on the cellular response to paclitaxel-induced microtubule damage
por: Nehmé, A, et al.
Publicado: (2000) -
Expression of the DNA mismatch repair proteins hMLH1 and hPMS2 in normal human tissues.
por: Fink, D., et al.
Publicado: (1997) -
Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells
por: Schwarz, V A, et al.
Publicado: (2002) -
The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells.
por: Fink, D., et al.
Publicado: (1998)